Ornithine lipid is a partial TLR4 agonist and NLRP3 activator
- Pizzuto, Malvina
- Hurtado-Navarro, Laura 1
- Molina-Lopez, Cristina 1
- Soubhye, Jalal
- Gelbcke, Michel
- Rodriguez-Lopez, Silvia
- Ruysschaert, Jean-Marie
- Schroder, Kate
- Pelegrin, Pablo 1
-
1
Universidad de Murcia
info
ISSN: 2211-1247
Argitalpen urtea: 2024
Alea: 43
Zenbakia: 10
Orrialdeak: 114788
Mota: Artikulua
Beste argitalpen batzuk: Cell Reports
Laburpena
Gram-negative bacterial lipopolysaccharides (LPSs) trigger inflammatory reactions through Toll-like receptor 4 (TLR4) and prime myeloid cells for inflammasome activation. In phosphate-limited environments, bacteria reduce LPS and other phospholipid production and synthesize phosphorus-free alternatives such as amino-acid-containing lipids like the ornithine lipid (OL). This adaptive strategy conserves phosphate for other essential cellular processes and enhances bacterial survival in host environments. While OL is implicated in bacterial pathogenicity, the mechanism is unclear. Using primary murine macrophages and human mononuclear cells, we elucidate that OL activates TLR4 and induces potassium efflux-dependent nucleotide-binding domain and leucine-rich repeat-containing pyrin protein 3 (NLRP3) activation. OL upregulates the expression of NLRP3 and pro-interleukin (IL)-1β and induces cytokine secretion in primed and unprimed cells. By contrast, in the presence of LPS, OL functions as a partial TLR4 antagonist and reduces LPS-induced cytokine secretion. We thus suggest that in phosphate-depleted environments, OL replaces LPS bacterial immunogenicity, while constitutively present OL may allow bacteria to escape immune surveillance.
Finantzaketari buruzko informazioa
Erreferentzia bibliografikoak
- Violi, (2023), Nat. Rev. Cardiol., 20, pp. 24, 10.1038/s41569-022-00737-2
- Fitzgerald, (2020), Preprint at Cell Press, 180, pp. 1044
- Bergkemper, (2016), Environ. Microbiol., 18, pp. 1988, 10.1111/1462-2920.13188
- Sosa, (2019), Environ. Microbiol., 21, pp. 2402, 10.1111/1462-2920.14628
- Vences-Guzmán, (2011), Mol. Microbiol., 79, pp. 1496, 10.1111/j.1365-2958.2011.07535.x
- Minnikin, (1974), FEBS Lett., 43, pp. 257, 10.1016/0014-5793(74)80655-1
- Benning, (1993), Proc. Natl. Acad. Sci. USA, 90, pp. 1561, 10.1073/pnas.90.4.1561
- López-Lara, (2003), Mol. Plant Microbe Interact., 16, pp. 567, 10.1094/MPMI.2003.16.7.567
- Geiger, (2010), Prog. Lipid Res., 49, pp. 46, 10.1016/j.plipres.2009.08.002
- Kim, (2018), Environ. Microbiol., 20, pp. 3992, 10.1111/1462-2920.14430
- Vences-Guzmán, (2012), FEMS Microbiol. Lett., 335, pp. 1, 10.1111/j.1574-6968.2012.02623.x
- Córdoba-Castro, (2021), Front. Mol. Biosci., 7, pp. 457, 10.3389/fmolb.2020.610932
- Comerci, (2006), J. Bacteriol., 188, pp. 1929, 10.1128/JB.188.5.1929-1934.2006
- Rojas-Jiménez, (2005), Mol. Plant Microbe Interact., 18, pp. 1175, 10.1094/MPMI-18-1175
- Sohlenkamp, (2007), Mol. Plant Microbe Interact., 20, pp. 1421, 10.1094/MPMI-20-11-1421
- Barbosa, (2018), Microbiology (United Kingdom), 164, pp. 395
- Laneelle, (1990), J. Gen. Microbiol., 136, pp. 773, 10.1099/00221287-136-4-773
- Okemoto, (2008), Biol. Pharm. Bull., 31, pp. 1952, 10.1248/bpb.31.1952
- Kawai, (1989), Infect. Immun., 57, pp. 2086, 10.1128/iai.57.7.2086-2091.1989
- Palacios-Chaves, (2011), PLoS One, 6, pp. e16030, 10.1371/journal.pone.0016030
- Kawai, (1991), Infect. Immun., 59, pp. 2560, 10.1128/iai.59.8.2560-2566.1991
- Lonez, (2015), Cell. Mol. Life Sci., 72, pp. 3971, 10.1007/s00018-015-1915-1
- Pizzuto, (2018), J. Contr. Release, 287, pp. 67, 10.1016/j.jconrel.2018.08.020
- Paramo, (2013), J. Biol. Chem., 288, pp. 36215, 10.1074/jbc.M113.501957
- Barton, (2003), Science, 300, pp. 1524, 10.1126/science.1085536
- Park, (2009), Nature, 458, pp. 1191, 10.1038/nature07830
- Kang, (2009), Immunity, 31, pp. 873, 10.1016/j.immuni.2009.09.018
- Broz, (2019)
- Kayagaki, (2011), Nature, 479, pp. 117, 10.1038/nature10558
- Hagar, (2013), Science, 341, pp. 1250, 10.1126/science.1240988
- Schroder, (2010), Cell, 140, pp. 821, 10.1016/j.cell.2010.01.040
- Kenakin, (2017), Pharmacology in Drug Discovery and Development, pp. 65, 10.1016/B978-0-12-803752-2.00004-1
- Gaidt, (2016), Immunity, 44, pp. 833, 10.1016/j.immuni.2016.01.012
- Yamasaki, (2009), J. Biol. Chem., 284, pp. 12762, 10.1074/jbc.M806084200
- Erdei, (2018), Oxid. Med. Cell. Longev., pp. 4310816, 10.1155/2018/4310816
- Babelova, (2009), J. Biol. Chem., 284, pp. 24035, 10.1074/jbc.M109.014266
- Lonez, (2014), Nanomedicine., 10, pp. 775, 10.1016/j.nano.2013.12.003
- He, (2019), Biochem. Biophys. Rep., 18, pp. 100623
- Li, (2018), Nanomedicine., 14, pp. 279, 10.1016/j.nano.2017.10.011
- Pizzuto, (2022), Prog. Lipid Res., 87, pp. 101182, 10.1016/j.plipres.2022.101182
- Alarcón-Vila, (2019), Curr. Opin. Pharmacol., 47, pp. 90, 10.1016/j.coph.2019.02.004
- Awate, (2013), Front. Immunol., 4, pp. 114, 10.3389/fimmu.2013.00114
- Pulendran, (2021), Nat. Rev. Drug Discov., 20, pp. 454, 10.1038/s41573-021-00163-y
- Demento, (2009), Vaccine, 27, pp. 3013, 10.1016/j.vaccine.2009.03.034
- Tahtinen, (2022), Nat. Immunol., 23, pp. 532, 10.1038/s41590-022-01160-y
- Kayagaki, (2013), Science, 341, pp. 1246, 10.1126/science.1240248
- Gay, (2014), Preprint, 14, pp. 546
- Ohto, (2012), Proc. Natl. Acad. Sci. USA, 109, pp. 7421, 10.1073/pnas.1201193109
- Kim, (2007), Cell, 130, pp. 906, 10.1016/j.cell.2007.08.002
- Matsuura, (2013), Front. Immunol., 4, pp. 109, 10.3389/fimmu.2013.00109
- Park, (2020), Virulence, 11, pp. 430, 10.1080/21505594.2020.1766401
- Shi, (2014), Nature, 514, pp. 187, 10.1038/nature13683
- Baker, (2015), Eur. J. Immunol., 45, pp. 2918, 10.1002/eji.201545655
- Zanoni, (2013), Front. Cell. Infect. Microbiol., 3, pp. 32, 10.3389/fcimb.2013.00032
- Aachoui, (2013), Science, 339, pp. 975, 10.1126/science.1230751
- Pizzuto, (2019), Cell. Mol. Life Sci., 76, pp. 3667, 10.1007/s00018-019-03113-5
- Gomi, (2002), J. Immunol., 168, pp. 2939, 10.4049/jimmunol.168.6.2939
- Jin, (2007), Cell, 130, pp. 1071, 10.1016/j.cell.2007.09.008
- Martinon, (2006), Nature, 440, pp. 237, 10.1038/nature04516
- Kuida, (1995), Science, 267, pp. 2000, 10.1126/science.7535475
- Mariathasan, (2004), Nature, 430, pp. 213, 10.1038/nature02664
- Curson, (2023), Eur. J. Immunol., 53, pp. e2250056, 10.1002/eji.202250056
- Hoshino, (1999), J. Immunol., 162, pp. 3749, 10.4049/jimmunol.162.7.3749
- Loke, (2012), Tetrahedron, 68, pp. 697, 10.1016/j.tet.2011.10.099
- Larionov, (2004), Org. Lett., 6, pp. 2153, 10.1021/ol049409+
- Martin, (2006), J. Med. Chem., 49, pp. 6000, 10.1021/jm060482a
- Livak, (2001), Methods, 25, pp. 402, 10.1006/meth.2001.1262